Previous Next

CURRENT ISSUE

№2' 2020

OBSTETRICS AND GYNECOLOGY

International Medical Journal, Vol. 26., Iss. 2, 2020, P. 25−28.


DOI (https://doi.org/10.37436/2308-5274-2020-2-5)

PLACENTAL DYSFUNCTION IN PREGNANT WOMEN WITH DIABETES. MODERN APPROACHES TO CHILDBIRTH


Viktoriia Valentinovna Lazurenko, Tertyshnyk D. Yu., Iryna Borysivna Borzenko, Liashchenko O. A., Ovcharenko O. B., Medviedieva M. O.

Kharkiv National Medical University
Municipal Non−Profit Enterprise of Kharkiv Regional Council "Kharkiv Regional Perinatal Center", Ukraine

Diabetes mellitus is a common chronic disease in the women of reproductive age. Pregnant women with this disease often have placental dysfunction, which manifests itself in fetal growth retardation, dehydration and requires delivery by a cesarean section. To evaluate the effect of antiprogesterone use on cervical maturation and optimization of delivery in pregnant women with placental dysfunction resulted from diabetes, 120 women were examined according to generally accepted norms. Ultrasound examination with Doppler velocimetry of the fetoplacental complex vessels and measurement of the uterus neck, hormonal examination to determine the level of hormones (progesterone, oxytocin, prostaglandin E2) by enzyme−linked immunosorbent assay, endothelial dysfunction factors (VEGF, endothelin, еNOS), assessment of uterus neck according to Bishops' score and the course of childbirth by cardiotocography and partogram, the newborn condition on the Apgar scores, newborn weight, glycometric condition of the mother. Preparation of pregnant women for childbirth was carried out by intracervical injection of prostaglandins of group E2 (dinoprostone); Foley catheter; antiprogesterone drug (mifepristone). The research has found that diabetes complicates the course of pregnancy with placental dysfunction in almost every second pregnant woman due to endothelial dysfunction, especially in the fetoplacental complex, which can be determined at an earlier stage of pregnancy by studying endothelial factors. The need for initiating the premature birth in pregnant women with diabetes is stipulated by the impairments in mother and fetus (placental dysfunction, diabetic fetopathy, distress), which requires preparation of the cervix for the labor induction. The most effective pre−induction of pregnant women with diabetes was the pathogenetic method of intracervical administration of antiprogesterone, which did not have a negative effect on the body of mother and child.

Key words: diabetes mellitus, placental dysfunction, pregnant women, antiprogesterone.


REFERENCES


1. Sugrue R., Zera C. Pregestational Diabetes in Pregnancy // Obstet. Gynecol. Clin. North Am. 2018. № 45 (2). R. 315−331. doi: 10.1016/j.ogc.2018.01.002. Review. PubMed PMID: 29747733

2. Prendergast C. Maternal phenotype: how do age, obesity and diabetes affect myometrial function? // Curr. Opin. Physiol. 2020. № 13. R. 108−116. doi: https://doi.org/10.1016/j.cophys.2019.10.016

3. Ten Years of Optimizing Outcomes for Women With Type 1 and Type 2 Diabetes in Pregnancy−The Atlantic DIP Experience / L. A. Owens, A. M. Egan, L. Carmody, F. Dunne // J. Clin. Endocrinol. Metab. 2016. № 101 (4). R. 1598−1605. doi: https://doi.org/10.1210/jc.2015−3817. Epub 2016 Jan 28. PubMed PMID: 26820715

4. Maternal overweight and obesity and risk of preeclampsia in women with type 1 diabetes or type 2 diabetes / M. Persson, S. Cnattingius, A. K. Wikström, S. Johansson // Diabetologia. 2016. № 59 (10). R. 2099−2105. doi: https://doi.org/10.1007/s00125−016−4035−z. Epub 2016 Jul 1. PubMed PMID: 27369871; PubMed Central PMCID: PMC5016540

5. Ringholm L., Damm P., Mathiesen E. R. Improving pregnancy outcomes in women with diabetes mellitus: modern management // Nat. Rev. Endocrinol. 2019. № 15 (7). R. 406−416. doi: https://doi.org/10.1038/s41574−019−0197−3. Review. PubMed PMID: 30948803

6. The importance of declining insulin requirements during pregnancy in patients with pre−gestational gestational diabetes mellitus / M. Ram, L. Feinmesser, S. Shinar, S. Maslovitz // Eur. J. Obstet. Gynecol. Reprod. Biol. 2017. № 215. R. 148−152. doi: https://doi.org/10.1016/j.ejogrb.2017.06.003. Epub 2017 Jun 3. PubMed PMID: 28628847

7. FIGO Pregnancy and NCD Committee. The first−trimester of pregnancy − A window of opportunity for prediction and prevention of pregnancy complications and future life / L. C. Poon et al. // Diabetes Res. Clin. Pract. 2018. Vol. 145. P. 20−30. doi: https://doi.org/10.1016/j.diabres.2018.05.002. Epub 2018 May 29. Review. PubMed PMID: 29852233

8. Ovcharuk V. V. Klіnіko−patogenetichnі aspekti dіagnostiki ta profіlaktiki platsentarnoї disfunktsії: dis. … kand. med. nauk: 14.01.01. Ternopіl', 2017. 213 s.

9. Goncharenko N. І. Osoblivostі stanu mіkrotsirkulyatsії ta endotelіal'noї funktsії mіkrosudin u vagіtnikh іz gestatsіinim dіabetom // Perinatologiya i pediatriya. 2015. № 4. S. 15−18. doi: https://doi.org/10.15574/pp.2015.64.15

10. Rozhkova O. V., Brusentsov I. G. Vozmozhnosti ul'trazvukovoi diagnostiki diabeticheskoi fetopatii pri gestatsionnom sakharnom diabete // Mat' i ditya v Kuzbasse. 2020. № 1. S. 32−37.

12. Sravnitel'nyi analiz sposobov podgotovki sheiki matki k rodam i iskhod rodov. Osobennosti primeneniya mifepristona dlya podgotovki sheiki matki k rodam / A. D. Naumov, K. V. Podgurskaya, V. S. Krishtal', M. V. Kosinets // Molodoi uchenyi. 2016. № 10. S. 517−521.

13. Lyalichkina N. A., Peshev L. P. Effektivnost' podgotovki sheiki matki i induktsii rodov mifepristonom // Sovremennye problemy nauki i obrazovaniya. 2015. № 6. S. 21−26.

14. Effect of mifepristone in cervical ripening for induction of labour / R. Athawale, N. Acharya, S. Samal, C. Hariharan // International J. of Reproduction, Contraception, Obstetrics and Gynecology. 2013. № 2 (1). R. 35−38. doi: https://doi.org/10.5455/2320−1770.ijrcog20130206

15. Nakaz MOZ Ukraїni vіd 15.07.2011 № 417 "Pro organіzatsіyu ambulatornoї akushers'ko−gіnekologіchnoї dopomogi v Ukraїnі".

16. Mahmoud E. A., Al−Bakri N. A., Qasim B. J. Histopathological changes of placenta in pregnant women complicated with pregestational diabetes // J. Pharm. Sci. Res. 2018. № 10 (11). R. 2952−2959.

Go on Top